H
Harlan M. Krumholz
Researcher at Yale University
Publications - 1966
Citations - 177853
Harlan M. Krumholz is an academic researcher from Yale University. The author has contributed to research in topics: Myocardial infarction & Population. The author has an hindex of 85, co-authored 1826 publications receiving 159216 citations. Previous affiliations of Harlan M. Krumholz include Veterans Health Administration & Robert Wood Johnson Foundation.
Papers
More filters
Journal ArticleDOI
Quality of care, process, and outcomes in elderly patients with pneumonia.
Thomas P. Meehan,Michael J. Fine,Harlan M. Krumholz,Jeanne D. Scinto,Deron Galusha,Joyce T. Mockalis,Georgina F. Weber,Marcia K. Petrillo,Peter M. Houck,Jonathan M. Fine +9 more
TL;DR: In this article, a multicenter retrospective cohort study with medical record review was conducted to assess quality of care for Medicare patients hospitalized with pneumonia and to determine whether process of care performance is associated with lower 30-day mortality.
Journal ArticleDOI
Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.
Daniel E. Forman,Javed Butler,Yongfei Wang,William T. Abraham,Christopher M. O'Connor,Stephen S. Gottlieb,Evan Loh,Barry M. Massie,Barry M. Massie,Michael W. Rich,Lynne W. Stevenson,James B. Young,Harlan M. Krumholz +12 more
TL;DR: Worsening renal function occurs frequently among hospitalized HF patients and is associated with significantly worse outcomes and clinical characteristics available at hospital admission can be used to identify patients at increased risk for developing WRF.
Journal ArticleDOI
Prevalence, Predictors, and Outcomes of Premature Discontinuation of Thienopyridine Therapy After Drug-Eluting Stent Placement: Results From the PREMIER Registry
John A. Spertus,Richard Kettelkamp,Clifton Vance,Carole Decker,Philip G. Jones,John S. Rumsfeld,John C. Messenger,Sanjaya Khanal,Eric D. Peterson,Richard G. Bach,Harlan M. Krumholz,David J. Cohen +11 more
TL;DR: Patients who stopped thienopyridine therapy by 30 days were more likely to die during the next 11 months and to be rehospitalized and strategies to improve the use of thienobyridines are needed to optimize the outcomes of MI patients treated with DES.
Journal ArticleDOI
Acute Myocardial Infarction in Women: A Scientific Statement from the American Heart Association
Laxmi S. Mehta,Theresa M. Beckie,Holli A. DeVon,Cindy L. Grines,Harlan M. Krumholz,Michelle N. Johnson,Kathryn J. Lindley,Viola Vaccarino,Tracy Y. Wang,Karol E. Watson,Nanette K. Wenger +10 more
TL;DR: This statement provides a comprehensive review of the current evidence of the clinical presentation, pathophysiology, treatment, and outcomes of women with acute myocardial infarction.
Journal ArticleDOI
Renal Impairment and Outcomes in Heart Failure: Systematic Review and Meta-Analysis
Grace L. Smith,Judith H. Lichtman,Michael B. Bracken,Michael G. Shlipak,Michael G. Shlipak,Christopher O. Phillips,Paul DiCapua,Harlan M. Krumholz +7 more
TL;DR: In this article, the authors estimated the prevalence of renal impairment in heart failure patients and the magnitude of associated mortality risk using a systematic review of published studies and found that renal impairment is associated with excess mortality, although precise risk estimates are unclear.